Stock listing

DYN Stock Price, News, Filings & Events — Dyne Therapeutics, Inc.

Selected listing: DYN · BX · CHF · CH

This page tracks Dyne Therapeutics, Inc.'s DYN:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DYN:BX. DYN:BX is the stock-level entry point for investors researching Dyne Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.